Leijon Helena, Salmenkivi Kaisa, Heiskanen Ilkka, Hagström Jaana, Louhimo Johanna, Heikkilä Päivi, Ristimäki Ari, Paavonen Timo, Metso Saara, Mäenpää Hanna, Haglund Caj, Arola Johanna
Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
APMIS. 2016 Sep;124(9):757-63. doi: 10.1111/apm.12571. Epub 2016 Jun 30.
Pheochromocytomas and paragangliomas are rare, neural crest-originating, neuroendocrine tumors. HuR is an mRNA-binding protein of the ELAV/Hu-protein family, which participates in posttranscriptional regulation of many cancer-associated genes. HuR expression has been connected with aggressive behavior of several malignancies. Cyclooxygenase-2 (COX-2) is also expressed in several malignant tumors, and its expression is regulated by HuR. Tissue microarray of 153 primary pheochromocytomas and paragangliomas was investigated for the expression of HuR and COX-2 proteins by immunohistochemistry using two different HuR antibodies (HuR19F12 and HuR3A). In these tumors, the expression of both intranuclear and cytoplasmic HuR was detectable. Increased cytoplasmic HuR expression was significantly associated with metastatic tumors. Increased COX-2 and MIB-1 expression also was associated with metastatic potential, and moreover, HuR and COX-2 expression correlated with each other. Our data suggest that increased expression of HuR protein is associated with metastatic potential of paragangliomas and pheochromocytomas, and COX-2 seems to be a target of HuR.
嗜铬细胞瘤和副神经节瘤是罕见的、起源于神经嵴的神经内分泌肿瘤。HuR是ELAV/Hu蛋白家族的一种mRNA结合蛋白,参与许多癌症相关基因的转录后调控。HuR的表达与多种恶性肿瘤的侵袭性行为有关。环氧化酶-2(COX-2)也在多种恶性肿瘤中表达,其表达受HuR调控。采用两种不同的HuR抗体(HuR19F12和HuR3A),通过免疫组织化学法对153例原发性嗜铬细胞瘤和副神经节瘤的组织芯片进行HuR和COX-2蛋白表达检测。在这些肿瘤中,细胞核和细胞质中的HuR表达均能被检测到。细胞质HuR表达增加与转移性肿瘤显著相关。COX-2和MIB-1表达增加也与转移潜能相关,此外,HuR和COX-2表达相互关联。我们的数据表明,HuR蛋白表达增加与副神经节瘤和嗜铬细胞瘤的转移潜能相关,COX-2似乎是HuR的一个靶点。